Average Insider

Where insiders trade, we follow

Insider Buy/Sell Ratio for March 2026

Extreme outlier transactions (>3ฯƒ) are excluded.Show All Data
Ratio0.2:1
Daily Buy & Sell Volume

By Sector

By Industry

Vaxcyte, Inc. (PCVX)

Cowan Elvia โ€” SVP, Finance & CAO
Mar 17, 2026
Sale
Shares
405
Price
$56.26
Total Value
$22.79K
Shares Held After
28,975
% of Holdings
1.4%

Vaxcyte, Inc. (PCVX)

Cowan Elvia โ€” SVP, Finance & CAO
Mar 17, 2026
Sale
Shares
1,487
Price
$55.39
Total Value
$82.36K
Shares Held After
29,380
% of Holdings
4.8%

BARRETT BUSINESS SERVICES INC (BBSI)

Potts James R โ€” EVP Gen Counsel & Secretary
Mar 17, 2026
Sale
Shares
1,803
Price
$28.68
Total Value
$51.71K
Shares Held After
33,837
% of Holdings
5.1%

Snowflake Inc. (SNOW)

Slootman Frank โ€” Director
Mar 17, 2026
Sale
Shares
7,874
Price
$175.34
Total Value
$1.38M
Shares Held After
38,046
% of Holdings
17.1%

Snowflake Inc. (SNOW)

Dageville Benoit โ€” Director
Mar 17, 2026
Sale
Shares
1,919
Price
$175.34
Total Value
$336.48K
Shares Held After
53,262
% of Holdings
3.5%
Mar 17, 2026
Sale
Shares
5,000
Price
$36.59
Total Value
$182.94K
Shares Held After
27,516
% of Holdings
15.4%
Mar 17, 2026
Purchase
Shares
3,695
Price
$11.94
Total Value
$44.12K
Shares Held After
9,991,577
% of Holdings
0.0%

Centessa Pharmaceuticals plc (CNTA)

Anderson Karen M. โ€” Chief People Officer
Mar 17, 2026
Sale
Shares
10,043
Price
$28.10
Total Value
$282.21K
Shares Held After
62,085
% of Holdings
13.9%

BLACKSTONE MORTGAGE TRUST, INC. (BXMT)

URBASZEK MARCIN โ€” Chief Financial Officer
Mar 17, 2026
Sale
Shares
452
Price
$19.13
Total Value
$8.65K
Shares Held After
26,176
% of Holdings
1.7%

Travel & Leisure Co. (TNL)

HERRERA GEORGE โ€” Director
Mar 17, 2026
Sale
Shares
1,214
Price
$70.48
Total Value
$85.56K
Shares Held After
3,601
% of Holdings
25.2%

WEX Inc. (WEX)

Kimball Jennifer โ€” Chief Accounting Officer
Mar 17, 2026
Sale
Shares
715
Price
$157.82
Total Value
$112.84K
Shares Held After
6,203
% of Holdings
10.3%

GAP INC (GAP)

Gruber Julie โ€” Chief Legal&Compliance Officer
Mar 17, 2026
Sale
Shares
74,217
Price
$23.85
Total Value
$1.77M
Shares Held After
53,970
% of Holdings
57.9%

GAP INC (GAP)

Breitbard Mark โ€” President & CEO, Gap Brand
Mar 17, 2026
Sale
Shares
119,155
Price
$23.80
Total Value
$2.84M
Shares Held After
135,884
% of Holdings
46.7%

GAP INC (GAP)

O'Connell Katrina โ€” Chief Financial Officer
Mar 17, 2026
Sale
Shares
119,155
Price
$23.80
Total Value
$2.84M
Shares Held After
11,503
% of Holdings
91.2%

GAP INC (GAP)

O'Connell Katrina โ€” Chief Financial Officer
Mar 17, 2026
Sale
Shares
34,258
Price
$24.00
Total Value
$822.19K
Shares Held After
130,658
% of Holdings
20.8%

AXON ENTERPRISE, INC. (AXON)

Nardini Erika โ€” Director
Mar 17, 2026
Sale
Shares
198
Price
$506.58
Total Value
$100.30K
Shares Held After
1,946
% of Holdings
9.2%

Adaptive Biotechnologies Corp (ADPT)

RUBINSTEIN JULIE โ€” President and COO
Mar 17, 2026
Sale
Shares
19,060
Price
$13.40
Total Value
$255.40K
Shares Held After
499,258
% of Holdings
3.7%

ALPHA PRO TECH LTD (APT)

RITOTA JOHN โ€” Director
Mar 17, 2026
Sale
Shares
2,260
Price
$4.94
Total Value
$11.16K
Shares Held After
41,355
% of Holdings
5.2%

SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Bhatt Padmanabh P. โ€” Sr. VP of IP, CSO
Mar 17, 2026
Sale
Shares
22,290
Price
$50.73
Total Value
$1.13M
Shares Held After
17,044
% of Holdings
56.7%

SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Bhatt Padmanabh P. โ€” Sr. VP of IP, CSO
Mar 17, 2026
Sale
Shares
27,710
Price
$49.95
Total Value
$1.38M
Shares Held After
39,334
% of Holdings
41.3%

IONIS PHARMACEUTICALS INC (IONS)

HOUGEN ELIZABETH L โ€” EVP, Finance & CFO
Mar 17, 2026
Sale
Shares
10,172
Price
$73.21
Total Value
$744.66K
Shares Held After
82,660
% of Holdings
11.0%
Mar 17, 2026
Purchase
Shares
219,118
Price
$1.96
Total Value
$429.47K
Shares Held After
762,834
% of Holdings
28.7%
Mar 17, 2026
Purchase
Shares
12,900
Price
$7.61
Total Value
$98.16K
Shares Held After
751,756
% of Holdings
1.7%

CYTOKINETICS INC (CYTK)

Blum Robert I โ€” Director
Mar 17, 2026
Sale
Shares
23,928
Price
$62.15
Total Value
$1.49M
Shares Held After
430,330
% of Holdings
5.3%

CYTOKINETICS INC (CYTK)

Blum Robert I โ€” Director
Mar 17, 2026
Sale
Shares
12,673
Price
$62.15
Total Value
$787.63K
Shares Held After
454,258
% of Holdings
2.7%
Shares
114
Price
$220.73
Total Value
$25.16K
Shares Held After
2,046,119
% of Holdings
0.0%
Shares
10
Price
$219.40
Total Value
$2.19K
Shares Held After
2,046,233
% of Holdings
0.0%
Shares
51
Price
$218.65
Total Value
$11.15K
Shares Held After
2,046,243
% of Holdings
0.0%
Shares
7,068
Price
$217.51
Total Value
$1.54M
Shares Held After
2,046,294
% of Holdings
0.3%
Shares
2,214
Price
$216.74
Total Value
$479.86K
Shares Held After
2,053,362
% of Holdings
0.1%
Shares
543
Price
$215.57
Total Value
$117.06K
Shares Held After
2,055,576
% of Holdings
0.0%

indie Semiconductor, Inc. (INDI)

Aoki Ichiro โ€” Director
Mar 17, 2026
Sale
Shares
50,000
Price
$2.59
Total Value
$129.44K
Shares Held After
100,952
% of Holdings
33.1%

CYTOKINETICS INC (CYTK)

Malik Fady Ibraham โ€” EVP Research & Development
Mar 17, 2026
Sale
Shares
4,397
Price
$62.15
Total Value
$273.27K
Shares Held After
153,902
% of Holdings
2.8%

CYTOKINETICS INC (CYTK)

Malik Fady Ibraham โ€” EVP Research & Development
Mar 17, 2026
Sale
Shares
7,636
Price
$62.15
Total Value
$474.58K
Shares Held After
158,299
% of Holdings
4.6%

GLOBAL PARTNERS LP (GLP)

Romaine Mark โ€” Chief Operating Officer
Mar 17, 2026
Sale
Shares
7,500
Price
$47.39
Total Value
$355.43K
Shares Held After
151,609
% of Holdings
4.7%

CYTOKINETICS INC (CYTK)

Callos Andrew โ€” EVP, Chief Commercial Officer
Mar 17, 2026
Sale
Shares
2,916
Price
$62.15
Total Value
$181.23K
Shares Held After
71,573
% of Holdings
3.9%

CYTOKINETICS INC (CYTK)

Callos Andrew โ€” EVP, Chief Commercial Officer
Mar 17, 2026
Sale
Shares
5,626
Price
$62.15
Total Value
$349.66K
Shares Held After
74,489
% of Holdings
7.0%

CYTOKINETICS INC (CYTK)

Lee Sung โ€” EVP, Chief Financial Officer
Mar 17, 2026
Sale
Shares
4,935
Price
$62.15
Total Value
$306.71K
Shares Held After
87,127
% of Holdings
5.4%

Limbach Holdings, Inc. (LMB)

Brooks Jayme L. โ€” Chief Financial Officer
Mar 17, 2026
Sale
Shares
1,100
Price
$81.40
Total Value
$89.54K
Shares Held After
140,750
% of Holdings
0.8%

Limbach Holdings, Inc. (LMB)

Brooks Jayme L. โ€” Chief Financial Officer
Mar 17, 2026
Sale
Shares
1,546
Price
$80.28
Total Value
$124.11K
Shares Held After
141,850
% of Holdings
1.1%

Limbach Holdings, Inc. (LMB)

Brooks Jayme L. โ€” Chief Financial Officer
Mar 17, 2026
Sale
Shares
460
Price
$78.80
Total Value
$36.25K
Shares Held After
143,396
% of Holdings
0.3%

Limbach Holdings, Inc. (LMB)

Brooks Jayme L. โ€” Chief Financial Officer
Mar 17, 2026
Sale
Shares
4,167
Price
$78.07
Total Value
$325.32K
Shares Held After
143,856
% of Holdings
2.8%

RECURSION PHARMACEUTICALS, INC. (RXRX)

Taylor Ben R โ€” Chief Financial Officer
Mar 17, 2026
Sale
Shares
7,956
Price
$3.39
Total Value
$26.97K
Shares Held After
1,180,318
% of Holdings
0.7%

Limbach Holdings, Inc. (LMB)

Brooks Jayme L. โ€” Chief Financial Officer
Mar 17, 2026
Sale
Shares
2,637
Price
$77.10
Total Value
$203.33K
Shares Held After
148,023
% of Holdings
1.8%

BiomX Inc. (PHGE)

Yeganeh Reuven โ€” Director
Mar 17, 2026
Sale
Shares
530,000
Price
$5.00
Total Value
$2.65M
Shares Held After
0
% of Holdings
100.0%

Lazard, Inc. (LAZ)

Orszag Peter Richard โ€” Director
Mar 17, 2026
Sale
Shares
2,000
Price
$41.66
Total Value
$83.32K
Shares Held After
210,942
% of Holdings
0.9%

Lazard, Inc. (LAZ)

Orszag Peter Richard โ€” Director
Mar 17, 2026
Sale
Shares
67,170
Price
$40.73
Total Value
$2.74M
Shares Held After
212,942
% of Holdings
24.0%
Mar 17, 2026
Sale
Shares
80
Price
$540.92
Total Value
$43.27K
Shares Held After
40,513
% of Holdings
0.2%
Mar 17, 2026
Sale
Shares
780
Price
$540.10
Total Value
$421.28K
Shares Held After
40,593
% of Holdings
1.9%
Mar 17, 2026
Sale
Shares
1,709
Price
$539.40
Total Value
$921.83K
Shares Held After
41,373
% of Holdings
4.0%
Version: v26.3.33